ArticleCurrent oncology (Toronto, Ont.)2024

A Novel Oncogenic and Drug-Sensitive KIF5B-NTRK1 Fusion in Lung Adenocarcinoma.

Hui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.